Johnson & Johnson has agreed to a proposed $5.5 billion settlement to resolve tens of thousands of lawsuits. It was alleged that its talc-based baby powder caused ovarian cancer. The healthcare giant continues to deny the allegations. However, the agreement could bring one of the biggest product liability cases in U.S. history closer to a definitive conclusion.
Key Takeaways
- $5.5 billion settlement covers approximately 69,000 U.S. talc-related lawsuits.
- The deal requires approval from 95% of eligible claimants before it can become final.
- Johnson & Johnson stopped selling talc-based baby powder in the U.S. in 2020 and globally in 2023.
Years of Court Battles
After more than a decade of litigation, Johnson & Johnson has reached a proposed settlement covering nearly all remaining U.S. lawsuits linking its talc-based products to ovarian cancer.
According to the company, the agreement resolves about 99.75% of outstanding talc claims in federal and state courts. However, it will only become effective if at least 95% of eligible plaintiffs agree to participate.
Thousands of Lawsuits
For years, consumers claimed that prolonged use of Johnson & Johnson baby powder and other talc products increased the risk of ovarian cancer. Some lawsuits also alleged contamination with asbestos, a known carcinogen.
The company has consistently rejected those claims, maintaining that scientific evidence shows its talc products are safe. In a statement, it reiterated:
“Studies show talc is safe, does not contain asbestos and does not cause cancer.”
Despite maintaining its position, the company transitioned to cornstarch-based baby powder, ending U.S. sales in 2020 before discontinuing talc products globally in 2023.
The Company’s Statement
J&J says the settlement is about ending years of costly legal disputes rather than admitting liability.
Erik Haas, the company’s Vice President of Litigation, described the allegations as “meritless” and said:
“While we are confident the company would have ultimately prevailed with further litigation, as it has in the vast majority of cases tried to date, this resolution allows the company to put this matter behind it and remain focused on its mission to develop medicines and devices that save lives.”
Lawyers representing thousands of plaintiffs also welcomed the agreement. According to them, it is a fair resolution after years of legal proceedings.
The Talc Controversy Goes On
Although the proposed agreement covers existing U.S. ovarian cancer claims, it does not include future lawsuits or ongoing cases outside the United States.
One of the largest remaining legal challenges is unfolding in the United Kingdom, where more than 7,000 potential claimants allege the company knowingly continued selling talc products despite cancer risks. The company has denied those allegations as well.
The issue also gained international attention after the World Health Organisation classified talc as “probably carcinogenic to humans” in 2024.
What Happens Next?
If enough claimants approve the proposal, the settlement could finally close one of the most closely watched product liability disputes involving the company.
While the company continues to defend the safety of its former talc products, the agreement represents a significant step toward resolving thousands of claims that have shaped its legal and corporate strategy for more than a decade.
FAQs
1. How much is the Johnson & Johnson settlement?
The proposed settlement is worth $5.5 billion.
2. Does Johnson & Johnson admit wrongdoing?
Johnson & Johnson continues to deny the allegations.
3. Is the settlement final?
The settlement requires approval from 95% of eligible claimants.
Stay tuned to Brandsynario for latest news and updates
Join a Channel
Brandsynario
Veryfilmi